FDA Updates

NOH is a rare, chronic, and debilitating drop in blood pressure upon standing. It is associated with Parkinson's disease, multiple system atrophy, and pure autonomic failure.

New Rx, generics, and OTC

Summer's not over yet. For customers planning August vacations or anyone with active children, here are some new options for the first-aid kit.

FDA has approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease (COPD). The long-acting beta-adrenergic agonist (LABA) by Boehringer Ingelheim Pharmaceuticals can be used once daily as maintenance therapy.

New Rx, generics, OTC, and devices for pharmacists.

A besetting problem in a screen-obsessed age, dry eye can be distractingly painful. Several companies offers products that promise relief.

Approximately 7.8% of adults and 10% of children in the U.S. are afflicted with hay fever symptoms. Pharmacists are able to offer a number of over-the-counter solutions to improve patients' quality of life.

FDA approved eslicarbazepine acetate on November 8, 2013 as an adjunctive treatment of partial-onset seizures in adults.

New Rx, generics, and OTC for pharmacists

Like oral medications, topical analgesics can offer patients well-controlled pain relief, but they do so without adverse systemic effects.

New Rx, formulations, indications, and generics

FDA has approved non-prescription esomeprazole 20mg (Nexium 24HR, Pfizer).

Bringing a new tool to the arsenal of medications to treat type 2 diabetes, FDA recently approved the only once-weekly injectable pen for adults with type 2 diabetes-exenatide extended-release for injectable suspension (AstraZeneca, Bydureon Pen).

In the pharmacy, an array of foot-care products awaits patients who can't stand it anymore.

New Rx, indications, generics, and OTC

Dr. Reddy’s Laboratories has launched moxifloxacin HCl tablets, 400 mg, a therapeutic equivalent generic version of Avelox on March 4, following FDA approval.

Teva Pharmaceutical Industries launched loxapine inhalation powder, 10 mg (Adasuve) March 3, for the acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults.

FDA approved droxidopa (Northera, Chelsea Therapeutics) capsules for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating condition that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.

FDA approved vortioxetine as oral tablets indicated for the treatment of major depressive disorder.

Brushes, toothpastes, rinses, whitestrips, and a gel pen -- lots of options for the dentally determined.

New Rx, generics, and OTC products for pharmacists

'Tis the season when cold-sufferers descend upon drugstores en masse.

New Rx, generics, and OTC for pharmacists

Some helpful preparations for patients to keep handy.

New Rx, generics, OTC, and devices

Product updates for pharmacists: New Rx, generic, and OTC

A peek into a very special world.

With its interpretation, HHS effectively eliminated approximately $1.50 per reminder in payments made to pharmacies by drug manufacturers.